Home Backup

Protecting Health, Promoting Life

The Kenya BioVax Institute was established in 2021 to manufacture and commercialize human vaccines and other health products and technologies.

Here is our Overview

Our Trending Story

Accelerating Vaccine and Therapeutic Production for Health Security in Africa

Featured Articles

On the Path to Production: BioVax Board Inspects Progress at Embakasi Facility

On the Path to Production: BioVax Board Inspects Progress at Embakasi Facility

The Chairman of the Board of Directors, Dr. Charles Githinji, led members of the Kenya BioVax Institute Limited Board on an inspection visit to the Embakasi manufacturing site to assess the ongoing enabling works and overall project progress. Accompanied by...

November 24, 2025

Harnessing Private Sector Efficiency in Vaccine Manufacturing

Post Types Updates

Harnessing Private Sector Efficiency in Vaccine Manufacturing

Kenya BioVax Institute Limited hosted a Workshop on Chartering the Roadmap to the First Vial, bringing together leadership, partners, and experts driving Kenya’s vaccine manufacturing agenda. Keynote Speaker Mr. Joe Sang, EBS, Managing Director – Kenya Pipeline Company Limited, delivered...

November 24, 2025

KBI through its research and development (R&D), partnerships and collaborations would contribute to the eradication of communicable and non-communicable diseases through novel vaccines and other biotherapeutics. Local vaccine manufacturing would assure access of vaccines to all in the country’s universal health coverage (UHC) agenda